Department of Congenital and Pediatric Heart Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Department of Congenital and Pediatric Heart Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany.
Int J Cardiol. 2024 Dec 15;417:132532. doi: 10.1016/j.ijcard.2024.132532. Epub 2024 Sep 5.
To assess the impact of low birth weight on early and late outcomes after staged palliation for single ventricle.
Patients after stage 1 palliation for single ventricle in our institution were retrospectively included and divided into two weight groups: 2.5 kg or less (low birth weight) and more than 2.5 kg. The impact of low birth weight on mortality and on the progression to further palliation stages (bidirectional Glenn, stage 2, and total cavopulmonary connection, stage 3) was assessed.
A total of 452 patients were included. Patients with low birth weight (n = 37, 8 %) had more frequently associated prematurity and extracardiac anomalies. Early and inter-stage mortality after stage 1 was higher in patients with low birth weight, so that less of these patients reached the next palliation stage (57 % vs. 77 %, p = 0.01, and 38 % vs. 56 %, p = 0.05, for stage 2 and stage 3, respectively). After 5 years, overall survival was inferior in patients with low birth weight (48 % vs. 73 %, p < 0.001). Survival conditioned by stage 2 palliation was inferior in patients with low birth weight compared to the reference group (76 % vs. 89 % after 5 years, p = 0.04). Low birth weight was a risk factor for death in most patients' subgroups, inclusive those with restricted pulmonary blood flow after a systemic-to-pulmonary shunt procedure.
During staged palliation of single-ventricle physiology, low birth weight has a detrimental impact on survival extending to beyond stage 2. This study calls for increased vigilance of these patients beyond the first interstage.
评估低出生体重对单心室分期姑息治疗后早期和晚期结局的影响。
本研究回顾性纳入我院行单心室一期姑息治疗的患者,并分为两组:体重 2.5kg 或以下(低出生体重)和体重超过 2.5kg。评估低出生体重对死亡率以及向进一步姑息治疗阶段(双向 Glenn、二期和全腔静脉肺动脉连接、三期)进展的影响。
共纳入 452 例患者。低出生体重组(n=37,8%)早产儿和心脏外畸形的比例更高。一期姑息治疗后早期和中期死亡率在低出生体重组患者中更高,因此这些患者到达下一个姑息治疗阶段的比例更低(二期为 57% vs. 77%,p=0.01,三期为 38% vs. 56%,p=0.05)。5 年后,低出生体重组患者的总生存率较低(48% vs. 73%,p<0.001)。与参考组相比,低出生体重组患者二期姑息治疗后的生存率较低(5 年后分别为 76%和 89%,p=0.04)。低出生体重是大多数患者亚组死亡的危险因素,包括在体肺分流术后肺血流量受限的患者。
在单心室生理的分期姑息治疗中,低出生体重对生存的影响是有害的,这种影响会延伸到二期之后。本研究呼吁在进行第一期中期治疗后,对这些患者进行更密切的监测。